Share this post on:

Product Name :
HPPH

Search keywords :
HPPH

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Photosensitizers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Zhejiang Hisun Pharmaceutical Co Ltd

Active Company_Name :
Zhejiang Hisun Pharmaceutical Co Ltd

Active Indication_Name:
Barrett Esophagus

In Active Indication_Name:
Precancerous Conditions

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDGFR alpha Antibody
Phospho-CDC37 (Ser13) Antibody (YA219)
Integrin beta 1 Antibody: Integrin beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Integrin beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related